Cybersecurity company SailPoint opened for trading on Thursday, returning to the markets more than two years after it went private.Maximize ...

OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, ...

Clinical-stage biopharmaceutical company Aardvark Therapeutics (AARD) priced its IPO of ~5.89M shares at $16.00 per share. All of the shares are being offered by Aardvark. The California-based startup ...

In trading on Tuesday, shares of Apogee Therapeutics Inc (Symbol: APGE) entered into oversold territory, hitting an RSI reading of 28.9, after changing hands as low as $34.22 per share.

SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...

Patent Secures Protection for RLF-TD011 in Epidermolysis Bullosa Wound Treatment GENEVA, SWITZERLAND / ACCESS Newswire / February 11, 2025 / RELIEF THERAPEUTICS ...

Cadrenal Therapeutics, a biopharmaceutical company listed on the Nasdaq under the ticker symbol CVKD, made a public announcement of leadership changes through an 8-K SEC filing on February 4, 2025.

Aardvark Therapeutics, Inc. ("Aardvark") (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...

Researchers compared how three antioxidants affected gray hair outcomes in mice: hesperetin, diosmetin, and luteolin, and ...

Shares of Neuphoria Therapeutics Inc. soared more than 11% in premarket trading on Wednesday, propelling the micro-cap ...

The HY primary saw two issues priced yesterday totaling US$1.45bn, pushing weekly volume to US$5.35bn and February supply to US$15.766bn. Year-to-date issuance stands at US$36.896bn, behind the ...

The syndicate led by Morgan Stanley, Goldman Sachs, JP Morgan and Evercore closed the books north of 20x covered on the back of strong long-only/mutual fund demand and a 100% hit rate in investor ...